欧洲肠外营养市场预测至 2030 年 - 区域分析 - 按营养素类型（单剂量氨基酸溶液、肠外脂质乳剂、碳水化合物、微量元素、维生素和矿物质）和最终用户（医院、诊所等）

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

No. of Pages: 90    |    Report Code: BMIRE00030424    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Parenteral Nutrition Market
Free Sample Buy Now
2022 年欧洲肠外营养市场价值为 24.0463 亿美元，预计到 2030 年将达到 39.5807 亿美元；预计 2022 年至 2030 年的复合年增长率为 6.4%。

营养不良和早产病例激增推动欧洲肠外营养市场发展

营养不良包括营养不足、超重或肥胖、维生素或矿物质不足以及因饮食不良而患有非传染性疾病。根据世界卫生组织 (WHO) 的数据，2021 年约有 19 亿成年人超重或肥胖，而 4.62 亿人体重不足。此外，3900 万 5 岁以下儿童超重，1.49 亿儿童因饮食中长期缺乏营养丰富的食物而生长发育迟缓，4500 万人消瘦（身高太瘦）。此外，5 岁以下儿童死亡中约有 45% 与营养不足有关。根据联合国国际儿童紧急基金会 (UNICEF) 2022 年 7 月的数据，营养不足的发生率从 2019 年的 8.0% 达到 2020 年的 9.3%； 2021 年，该比例进一步跃升至 9.8%。

根据欧洲专科营养研究，2019 年欧洲约有 40% 的住院成年患者营养不良。根据 2021 年发表的一项题为“医院营养不良多中心调查”的研究，英格兰医院和家庭护理环境中约有 11-45% 的患者营养不良。根据需要通过肠外方法提供的营养支持是治疗大多数营养不良病例的重要且合适的方法。

早产是指婴儿在相当早的阶段出生，即在怀孕 37 周之前出生。根据世卫组织 2023 年发布的数据，2020 年全球报告的早产病例约为 1340 万例（占出生婴儿总数的十分之一以上）。低收入国家平均有 12% 的婴儿早产，而高收入国家这一比例为 9%。大量早产儿体重过轻且免疫力不发达，危及他们的生命。由于早产并发症导致吸吮或吞咽困难，或由于神经肌肉、心脏或其他疾病，早产儿更倾向于肠外营养。当出生后无法通过肠内途径安全满足估计的能量和营养需求时，肠外营养 (PN) 是早产新生儿和婴儿常规营养护理的一部分。

因此，儿童和成人营养不良的巨大负担以及大量的早产推动了对肠外营养配方和产品的需求，从而推动了市场的发展。

欧洲肠外营养市场概览

在德国，有几起与超重、肥胖和营养不良有关的病例。根据罗伯特·科赫研究所的数据，2022 年约有三分之二的男性和超过一半的女性超重。营养不足会导致恶性肿瘤患者出现不良结果并降低生活质量。活动性肿瘤患者通常缺乏足够的食物；因此，肠外和肠内营养用于预防或减少逐渐减轻的体重。根据德国科学医学协会的说法，患有严重胃肠道缺陷（如放射性肠炎）的患者可以从肠外营养中受益。在大多数情况下，人工营养可以稳定或增加体重和体脂量。

此外，德国幽门螺杆菌感染的发病率很高，这是导致胃癌的重要原因。根据《临床微生物学与感染》杂志 (ELSEVIER) 的一项研究 (2020)，幽门螺杆菌感染了德国约 25% 的总人口，并引起了胃炎，而胃腺癌会变得更加复杂。此外，德国的胃癌发病率很高，这促进了该国的诊断程序。根据国际癌症研究机构的最新数据，德国胃癌的年龄标准化发病率估计为每 100,000 人 7 人，粗发病率为 18.29。上述因素正在推动德国肠外营养市场的发展。

欧洲肠外营养市场收入及预测至 2030 年（百万美元）

欧洲肠外营养市场细分

欧洲肠外营养市场根据营养类型、最终用户和国家进行细分。根据营养类型，欧洲肠外营养市场分为单剂量氨基酸溶液、肠外脂质乳剂、碳水化合物、微量元素以及维生素和矿物质。单剂量氨基酸溶液部分在 2022 年占据了最大的市场份额。

按最终用户划分，欧洲肠外营养市场分为医院、诊所和其他。医院部门在 2022 年占据了最大的市场份额。

根据国家/地区，欧洲肠外营养市场细分为。德国在 2022 年占据了欧洲肠外营养市场份额的主导地位。

ICU Medical Inc、Grifols SA、辉瑞公司、大冢制药有限公司、百特国际公司、B Braun SE、Fresenius Kabi AG、Aculife Healthcare Pvt Ltd 和 Vifor Pharma Management AG 是欧洲肠外营养市场的一些领先参与者。

Europe Parenteral Nutrition Strategic Insights

Strategic insights for Europe Parenteral Nutrition involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-parenteral-nutrition-market-strategic-framework.webp
Get more information on this report

Europe Parenteral Nutrition Report Scope

Report Attribute Details
Market size in 2022 US$ 2,404.63 Million
Market Size by 2030 US$ 3,958.07 Million
Global CAGR (2022 - 2030) 6.4%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 营养成分类型
  • 单剂量氨基酸溶液
  • 肠外脂肪乳剂
  • 碳水化合物
  • 微量元素
  • 维生素和矿物质
By 最终用户
  • 医院
  • 诊所
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • ICU Medical Inc
  • Grifols SA
  • Pfizer Inc
  • Otsuka Pharmaceuticals Co Ltd
  • Baxter International Inc
  • B Braun SE
  • Fresenius Kabi AG
  • Aculife Healthcare Pvt Ltd
  • Vifor Pharma Management AG
    		•
    Get more information on this report

    Europe Parenteral Nutrition Regional Insights

    The regional scope of Europe Parenteral Nutrition refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-parenteral-nutrition-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - Europe Parenteral Nutrition Market

    1. ICU Medical Inc
    2. Grifols SA
    3. Pfizer Inc
    4. Otsuka Pharmaceuticals Co Ltd
    5. Baxter International Inc
    6. B Braun SE
    7. Fresenius Kabi AG
    8. Aculife Healthcare Pvt Ltd 
    9. Vifor Pharma Management AG

    Frequently Asked Questions
    How big is the Europe Parenteral Nutrition Market?

    The Europe Parenteral Nutrition Market is valued at US$ 2,404.63 Million in 2022, it is projected to reach US$ 3,958.07 Million by 2030.

    What is the CAGR for Europe Parenteral Nutrition Market by (2022 - 2030)?

    As per our report Europe Parenteral Nutrition Market, the market size is valued at US$ 2,404.63 Million in 2022, projecting it to reach US$ 3,958.07 Million by 2030. This translates to a CAGR of approximately 6.4% during the forecast period.

    What segments are covered in this report?

    The Europe Parenteral Nutrition Market report typically cover these key segments-

  • 营养成分类型 (单剂量氨基酸溶液, 肠外脂肪乳剂, 碳水化合物, 微量元素, 维生素和矿物质)
  • 最终用户 (医院, 诊所)

    • What is the historic period, base year, and forecast period taken for Europe Parenteral Nutrition Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Parenteral Nutrition Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
    • Who are the major players in Europe Parenteral Nutrition Market?

    The Europe Parenteral Nutrition Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • ICU Medical Inc
  • Grifols SA
  • Pfizer Inc
  • Otsuka Pharmaceuticals Co Ltd
  • Baxter International Inc
  • B Braun SE
  • Fresenius Kabi AG
  • Aculife Healthcare Pvt Ltd
  • Vifor Pharma Management AG
    • Who should buy this report?

    The Europe Parenteral Nutrition Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Parenteral Nutrition Market value chain can benefit from the information contained in a comprehensive market report.

    europe-parenteral-nutrition-market